Carlos Linn

420 citations
15 papers · 283 indexed · 1 hit paper · h-index 6
Topics
Lung Cancer Treatments and Mutations (4 papers)Advanced Breast Cancer Therapies (3 papers)Ovarian cancer diagnosis and treatment (3 papers)

In The Last Decade

Carlos Linn

14 papers receiving 282 citations

Hit Papers

Chemotherapy with or without avelumab followed by aveluma...2021202620222024202150100150

Peers

Carlos Linn
Comparison fields: 5 of 38
  • Oncology 198
  • Reproductive Medicine 102
  • Immunology 96
  • Pulmonary and Respiratory Medicine 87
  • Molecular Biology 34
Replace Ningning Li with:
Ningning Li China
Sebastien Hazard United States
Maria Kfoury France
Sammy Yuan United States
Koji Nishino Japan
Christopher McCann United Kingdom
Beata Maćkowiak-Matejczyk Poland
Liselore Loverix Belgium
Elena Giudice Italy
Alejandra Wernicke Argentina
Carlos Linn relative to Ningning Li China Ningning Li's profile →
Citations per field
00.5×
Ningning Li · 1×
Citations per year

Countries citing papers authored by Carlos Linn

Since Specialization
Citations

This map shows the geographic impact of Carlos Linn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Linn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Linn more than expected).

Fields of papers citing papers by Carlos Linn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Linn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Linn. The network helps show where Carlos Linn may publish in the future.

Co-authorship network of co-authors of Carlos Linn

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Linn. A scholar is included among the top collaborators of Carlos Linn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Linn. Carlos Linn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 2
2 9
3 11
4
Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trialbreakdown →
160
5 5
6 43
7 1
8 3
9 4
10 3
11 1
12 22
13 17
14 2
15 0

About Carlos Linn

Carlos Linn is a scholar working on Gastroenterology, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 283 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Advanced Breast Cancer Therapies (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). The work is most often cited by research in Reproductive Medicine (102 citations), Oncology (198 citations) and Immunology (96 citations). Carlos Linn has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Joohyuk Sohn, Elena Poddubskaya, Leslie M. Randall, Giovanni Scambia, Kan Yonemori, Amit M. Oza, Yaroslav Shparyk, Ross Stewart, Bradley J. Monk and Julia Perkins Smith. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026